
Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
Keywords: نظارت بر دارودرمانی; Monoclonal Antibody; Personalized Medicine; Pharmacokinetics; Therapeutic Drug Monitoring; ATI; antibodies to infliximab; CD; Crohn's disease; CRP; C-reactive protein; HBI; Harvey-Bradshaw Index; IBD; inflammatory bowel disease; IQR; interquartile range